Author

N. Bosquet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:non-human primate· 6 Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

R. Le Grand· 6 shared V. Contreras· 4 shared F. Relouzat· 3 shared A.-S. Gallouët· 2 shared B. Vaslin· 2 shared F. Follmann· 2 shared I. Rosenkrands· 2 shared O. Lambotte· 2 shared

Activity by Year

2017-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersImmunology

R. Le Grand

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Multimodal mucosal and systemic immune characterization of a novel non-human primate trachoma model highlights the critical role of local immunity during acute phase disease

E. Paulet, V. Contreras, M. Galhaut, I. Rosenkrands, M. Holland, M. Burton, J. Dietrich, A.-S. Gallouët, N. Bosquet, F. Relouzat, S. Langlois, F. Follmann, R. Le Grand, M. Labetoulle, A. Rousseau

This study develops a non-human primate model of acute trachoma and characterizes the local immune response kinetics following Chlamydia trachomatis infection.

bioRxiv · Dec 5, 2023Microbiology

ACE2 mimetic antibody potently neutralizes all SARS-CoV-2 variants and fully protects in XBB.1.5 challenged monkeys

C. Fenwick, P. Turelli, Y. Duhoo, K. Lau, C. Herate, R. Marlin, M. Lamrayah, J. Campos, L. Leuenberger, A. Farina, c. raclot, V. Genet, F. Fiscalini, J. Cesborn, L. Perez, , G. Pantaleo

bioRxiv · Jul 18, 2023 · PreprintMicrobiology

A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates

J. S. Woodworth, V. Contreras, D. Christensen, T. Naninck, N. Kahlaoui, A.-s. Gallouët, S. Langlois, E. Burban, C. Joly, W. Gros, N. Bosquet, J. Morin, M. L. Olsen, I. Rosenkrands, A.-K. Stein, , R. Mortensen

This paper develops a novel liposomal adjuvant, CAF(R)10b, that induces robust Th1/Th17 memory and mucosal recall responses in non-human primates.

bioRxiv · Feb 23, 2023 · PreprintImmunology

Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects Macaques from infection

G. Sulbaran, P. Maisonnasse, A. Amen, D. Guilligay, N. Bosquet, J. A. Burger, M. Poniman, M. Buisson, S. D. Dylon, T. Naninck, J. Lemaitre, W. Gros, A.-S. Gallouet, R. Marlin, C. Bouillier, , W. Weissenhorn

This study develops a synthetic SARS-CoV-2 S glycoprotein virus-like particle vaccine that protects macaques from infection through strong antibody and T cell responses.

bioRxiv · Jul 26, 2021Immunology

Optimal maturation of the SIV-specific CD8+ T-cell response after primary infection is associated with natural control of SIV. ANRS SIC study

C. Passaes, A. Millet, V. Madelain, V. Monceaux, A. David, P. Versmisse, N. Sylla, E. Gostick, D. A. Price, A. Blancher, N. Bosquet, G. Pancino, R. Le Grand, O. Lambotte, M. Muller-Trutwin, , A. Saez-Cirion

This study shows that optimal maturation of SIV-specific CD8+ T-cells correlates with natural control of SIV infection in macaques, with controllers developing more potent antiviral responses over time.

bioRxiv · Dec 20, 2019Immunology

Stage-specific ISG expression reveals functional convergence of type I and II IFNs in SIV infection

N. Echebli, N. Tchitchek, S. Dupuy, T. Bruel, C. Pereira Bittencourt Passaes, N. Bosquet, R. Le Grand, C. Bourgeois, B. Favier, R. Cheynier, O. Lambotte, B. Vaslin

The paper analyzes ISG expression in SIV-infected macaques to show that both type-I and type-II IFNs contribute to ISG upregulation, with type-II IFN persisting during chronic infection.

bioRxiv · Sep 22, 2017Immunology